ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,493Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 252

$814K Total Retail Price of All Prescriptions

Rank: 30 out of 252

545 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 545 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 545 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 12,293 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LISINOPRIL 617 544 1 3
LEVOTHYROXINE SODIUM 577 485 2 1
SIMVASTATIN 511 466 3 2
HYDROCHLOROTHIAZIDE 421 361 4 13
FUROSEMIDE 351 321 5 7
OMEPRAZOLE 347 304 6 6
HYDROCODONE-ACETAMINOPHEN 345 251 S3 7 5
AMLODIPINE BESYLATE 311 276 8 4
METFORMIN HCL 310 245 9 9
DONEPEZIL HCL 299 299 10 28
NAMENDA 283 283 11 41
WARFARIN SODIUM 280 263 12 14
ATENOLOL 244 202 13 18
CARVEDILOL 226 219 14 22
CYMBALTA 220 183 15 45
METOPROLOL SUCCINATE 215 195 16 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 202 176 17 25
NEXIUM 198 119 18 23
POTASSIUM CHLORIDE 184 180 19 8
GABAPENTIN 179 146 20 11
ENALAPRIL MALEATE 174 150 21 72
LOVAZA 174 141 21 172
METOPROLOL TARTRATE 172 125 23 10
TRAZODONE HCL 169 136 24 31
MELOXICAM 163 110 25 20
CRESTOR 158 130 26 34
PRAVASTATIN SODIUM 158 143 26 12
RANITIDINE HCL 155 137 28 48
TAMSULOSIN HCL 150 142 29 26
SERTRALINE HCL 145 131 30 27
CITALOPRAM HBR 141 120 31 15
ATORVASTATIN CALCIUM 140 126 32 16
GLYBURIDE 140 129 R 32 78
AVODART 140 140 32 187
PREDNISONE 134 116 35 42
DOXAZOSIN MESYLATE 125 122 36 73
AMITRIPTYLINE HCL 120 89 R 37 46
CLOPIDOGREL 115 88 38 29
ALLOPURINOL 111 102 39 30
FLUOXETINE HCL 103 87 40 57
LANTUS 99 94 41 55
CIPROFLOXACIN HCL 89 81 42 61
GLYBURIDE-METFORMIN HCL 89 84 R 42 82
FLUTICASONE PROPIONATE 88 85 44 36
SPIRIVA 87 66 45 68
ESCITALOPRAM OXALATE 86 57 46 56
ZETIA 85 69 47 97
TRAMADOL HCL 83 79 48 17
LOSARTAN POTASSIUM 79 69 49 24
ADVAIR DISKUS 75 66 50 63
DIGOXIN 73 63 51 44
CLONIDINE HCL 71 53 52 35
PLAVIX 68 58 53 43
AMOXICILLIN 64 55 54 122
VESICARE 62 62 55 183
AMLODIPINE BESYLATE-BENAZEPRIL 60 48 56 60
ISOSORBIDE MONONITRATE ER 59 59 57 50
GLIPIZIDE 58 22 58 52
PROAIR HFA 55 46 59 54
DIOVAN 55 46 59 38
LOVASTATIN 52 45 61 39
AZITHROMYCIN 51 36 62 37
QUETIAPINE FUMARATE 51 42 62 77
OXYBUTYNIN CHLORIDE ER 50 50 64 181
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.